InMode Ltd. (INMD)
NASDAQ: INMDHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
INMD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $714.70M
- P/E (TTM)
- 10.44
- Forward P/E
- 9.15
- EPS (TTM)
- $1.19
- Dividend yield
- None
- 52-week range
- 12.40 – 16.67
- Day range
- 12.40 – 12.67
- Volume / Avg
- 707.55K / 529.24K
- Beta
- —
- Shares outstanding
- 57.54M
52-week range
INMD stock today
InMode (INMD) closed at $12.42 on Nov 20, down 2.20% (-$0.28), versus the S&P 500's 3.70% decline. At this level, INMD sits near the bottom of its 52-week range of $12.40 to $16.67: 25.5% below the high, set on Feb 2, 2026 and 0.2% above the low. INMD is down 15.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 11.7%.
InMode trades at 10.4x its trailing twelve-month earnings per share of $1.19. Its forward P/E of 9.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About InMode
Company profileInMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CEO
- Mr. Moshe Mizrahy
- Headquarters
- Yokne'am
- Employees
- 660
- IPO year
- 2019
- Website
- inmodemd.com
Financial highlights
Full financialsIn fiscal 2025, InMode generated $370.5 million in revenue, down 6.2% from fiscal 2024, its first annual decline since 2024. Net income was $93.8 million (-48.2% year over year), for a net margin of 25.3% versus a median of 40.2% in the prior 5 years. Gross margin was 78.5% (down from 80.3%) and operating margin 23.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $370.50M | $394.82M | $492.05M | $454.27M | $357.56M |
| Growth | -6.16% | -19.76% | +8.32% | +27.05% | +73.49% |
| Net income | $93.83M | $181.28M | $197.92M | $161.52M | $164.97M |
| EPS (diluted) | $1.43 | $2.25 | $2.30 | $1.89 | $1.92 |
Analyst forecast
ForecastConsensus (5 analysts)
hold
Avg. price target
$14.67+18.12%
- Strong buy 0
- Buy 0
- Hold 5
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 11, 2026
- EPS actual vs est.
- $0.32 vs —
INMD news
All INMD news- InMode Ltd. Reports Third Quarter 2026 GAAP Revenues of $92.1 MillionNasdaq
- InMode reports Q3 earnings above street expectationsSeeking Alpha
- InMode Reports Third Quarter 2026 Financial Results: Quarterly GAAP Revenues of $92.1 Million; Reaffirms Full-Year 2026 Financial OutlookPR Newswire
- InMode Q3 2026 Earnings PreviewSeeking Alpha
- InMode Ltd. Special Committee Issues October 26, 2026 Update on Strategic ReviewNasdaq
- InMode expects Q3 revenue between $91.8M and $92MSeeking Alpha
InMode peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CBLLCeriBell Inc. | 27.39 | +6.37% | $1.06B | vs INMD |
| CVCapsoVision Inc. | 6.11 | -3.17% | $327.56M | vs INMD |
| ELMDElectromed Inc. | 22.98 | -1.20% | $187.84M | vs INMD |
| FOCLEDAP TMS S.A. ADR | 2.61 | -7.45% | $123.25M | vs INMD |
| VANIVivani Medical Inc. | 1.14 | +4.59% | $102.83M | vs INMD |
| STXSStereotaxis Inc. | 0.9422 | -6.71% | $95.03M | vs INMD |
| HSDTSolana Company Class A | 1.49 | -10.24% | $93.70M | vs INMD |
| NRXSNeuraxis Inc. | 4.22 | -6.22% | $59.90M | vs INMD |
Indexes, lists and sector
InMode stock FAQ
What is InMode's stock price today?
INMD last traded at $12.42 as of Nov 20, 4:00 PM EST, down 2.20% on the day. Prices are delayed at least 15 minutes.
Does InMode pay a dividend?
No. InMode does not currently pay a regular cash dividend.
What is INMD's P/E ratio?
INMD trades at a trailing P/E ratio of 10.44 and a forward P/E of 9.15.
Who is InMode's CEO?
Mr. Moshe Mizrahy is the chief executive officer of InMode Ltd., which has about 660 employees.
Has INMD ever split its stock?
Yes. The most recent INMD stock split was a 2-for-1 split on Oct 1, 2021.
What is the INMD 52-week high?
The 52-week high for INMD is $16.67 and the 52-week low is $12.40. The stock is currently 25.5% below its high.